Voyager Therapeutics (VYGR) FCF Margin Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96,154.00 |
| Dec 31, 2025 | 18,967.00 |
| Sep 30, 2025 | -20,788.00 |
| Jun 30, 2025 | -58,040.00 |
| Mar 31, 2025 | -42,539.00 |
| Dec 31, 2024 | -13,902.00 |
| Sep 30, 2024 | -2,275.00 |
| Jun 30, 2024 | -3,463.00 |
| Mar 31, 2024 | -211,779.00 |
| Dec 31, 2023 | 101,194.00 |
| Sep 30, 2023 | 40,866.00 |
| Jun 30, 2023 | 94,506.00 |
| Mar 31, 2023 | -507,587.00 |
| Dec 31, 2022 | 108,642.00 |
| Sep 30, 2022 | 166,859.00 |
| Jun 30, 2022 | -159,825.00 |
| Mar 31, 2022 | 637,479.00 |
| Dec 31, 2021 | 75,672.00 |
| Sep 30, 2021 | -111,869.00 |
| Jun 30, 2021 | -145,075.00 |
| Mar 31, 2021 | -12,187.00 |
| Dec 31, 2020 | -19,456.00 |
| Sep 30, 2020 | 11,660.00 |
| Jun 30, 2020 | 7,271.00 |
| Mar 31, 2020 | -266,921.00 |